Oxford Drug Design Limited
04305857
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 29/10/2025
Due 12/11/2026
Industry
Officers
director · Since 16/11/2020
CHIEF EXECUTIVE OFFICER
POLISH · ENGLAND · Age 65
Also on 2 other boards
secretary · Since 17/04/2023
Persons with Significant Control
Former PSCs
Ip Venture Fund (Gp) Limited
Ceased 29/07/2019
Mr Michael Underwood
Ceased 20/05/2019
Ip2ipo Limited
Ceased 29/07/2019
CompanyRankvs 49+ SIC 72110 peers86
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£875k
Balance sheet strength
Cash
£432k
Cash in the bank
Net Current Assets
£283k
Working capital
Current Assets
£548k
Current Liabilities
£265k
Fixed Assets
£4k
Debtors
£116k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 2.07 | +£0 |
| 2023 | 11.80 | +£0 |
| 2022 | 12.05 | +£300k |
| 2021 | 4.19 | +£0 |
| 2020 | 4.71 | — |
Derived from filed accounts. Not audited figures.